Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Premium
ValueAct Launches a New Japan Fund
Stephen Taub
January 12, 2023
Premium
Citadel Posts Its Biggest Gain in Over a Decade
Stephen Taub
,
Ava Luisa
,
Ailene Barona
,
Ailene The Tester
January 6, 2023
Premium
Hedge Fund Favorites Limp to the Finish Line
Stephen Taub
January 3, 2023
Premium
Greenlight Ends 2022 on a High Note
Stephen Taub
January 3, 2023
Premium
Greenlight Ends 2022 on a High Note
Stephen Taub
January 3, 2023
Premium
Biopharma Funds Are Still Embracing VC
Stephen Taub
December 21, 2022
Premium
Tech Funds Shun VC Investments
Stephen Taub
December 20, 2022
Premium
JW Asset Management Has a Sobering Year
Stephen Taub
December 19, 2022
Premium
It’s Been a Bad Year for IPOs — But Hedge Funds Are Betting on These New Offerings
Stephen Taub
December 16, 2022
Premium
The Prognosis Brightens for Biopharma Funds
Stephen Taub
December 14, 2022
Premium
The Hedge Funds Behind the Coupa Deal
Stephen Taub
December 13, 2022
Premium
Light Street’s 2022 Keeps Getting Worse
Stephen Taub
December 12, 2022
Premium
Third Point Struggles in November
Stephen Taub
December 8, 2022
Citadel Stays Ahead of the Multistrat Pack
Stephen Taub
December 7, 2022
Premium
Citadel Stays Ahead of the Multistrat Pack
Stephen Taub
December 7, 2022
Premium
Another Round of Gains for Glenview
Stephen Taub
December 6, 2022
Another Round of Gains for Glenview
Stephen Taub
December 6, 2022
Premium
Macro Takes a Beating in November
Stephen Taub
December 6, 2022
More Articles